NERV - Minerva Neurosciences GAAP EPS of -$1.29 beats by $0.03
- Minerva Neurosciences press release ( NASDAQ: NERV ): Q3 GAAP EPS of -$1.29 beats by $0.03 .
- Cash, cash equivalents and restricted cash as of September 30, 2022 were approximately $40.3 million, compared to $60.9 million as of December 31, 2021.
- The Company expects that its existing cash and cash equivalents will be sufficient to meet its anticipated capital requirements for at least the next 12 months based on its current operating plan.
For further details see:
Minerva Neurosciences GAAP EPS of -$1.29 beats by $0.03